Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-11 · accession 0001048477-24-000063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-15 | 2024-04-11+ | BMRN | BIENAIME JEAN JACQUES | Dir | S - Sale+OE | $91.12 | -40.0K | 475.0K | -8% | -$3.65M |
| DM | 2024-04-15 | 2024-04-11+ | BMRN | BIENAIME JEAN JACQUES | Dir | M - OptEx | $63.10 | +40.0K | 495.0K | +9% | +$2.52M |
| DM | 2024-04-15 | 2024-04-11+ | BMRN | BIENAIME JEAN JACQUES | Dir | M - OptEx | $0.00 | -40.0K | 91.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-12 | S | D | 20,000 | $91.26 | 474,994 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 2 | Common | Common Stock | 2024-04-12 | M | A | 20,000 | $63.10 | 494,994 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 3 | Common | Common Stock | 2024-04-11 | M | A | 20,000 | $63.10 | 494,994 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 4 | Common | Common Stock | 2024-04-11 | S | D | 20,000 | $90.99 | 474,994 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. |
| 5 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-04-11 | M | D | 20,000 | $0.00 | 111,000 | D | $63.10 · 2014-12-04 to 2024-06-03 | 20,000 Common Stock | (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 6 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-04-12 | M | D | 20,000 | $0.00 | 91,000 | D | $63.10 · 2014-12-04 to 2024-06-03 | 20,000 Common Stock | (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |